Connecting minds and sharing knowledge to improve melanoma outcomes

 

The Melanoma Research and Therapy Special Interest Group brings together clinicians and researchers from across New Zealand to tackle the big challenges in melanoma care.

Our goals are to:

  • Reach consensus on current issues and turn solutions into action

  • Raise standards of care by promoting and driving melanoma research

 


Join us for the next meeting

To be held in conjunction with New Zealand
Society of Oncology conference

 

Time: 10.15 - 11.45 am
Date: Thursday 9 October 2025
Venue: Dunedin Centre, Dunedin
Cost: Please see NZSO website for registration fees

 

We are excited to be hosting Dr Ashani Weeraratna, a world-renowned expert on melanoma metastasis, Wnt signaling and aging at this meeting. Dr Weeraratna will be presenting on "Age against the Machine: understanding Melanoma in the context of the aging human body". This is one you won't want to miss!

 

   Register here              

 

 

Past meetings


7 October 2024
Auckland (NZSO)
_______

Topics discussed:

  • Cutaneous cancer clinical trials: pearls, pitfalls and possibilities 
  • Management of immune checkpoint inhibitor induced colitis 

21 September 2023
Auckland (NZSO)

_______

Topics discussed: 

  • Adjuvant and neo-adjuvant therapy and contemporary melanoma surgery  
  • Real-world outcomes of immunotherapy for melanoma brain metastases in New Zealand

4 November 2022
Online
_______


Topics discussed: 

  • Improving access to clinical trials in New Zealand
  • Research into DNA and RNA signatures associated with melanoma resistance to Keytruda

27 November 2020
Online
_______


Topics discussed: 

  • Advocating for funded adjuvant treatment in New Zealand
  • Melanoma research: An update from MASC Trials
 
26 June 2020
Online
_______


Topics discussed: 

  • National melanoma immunotherapy database  
  • Feedback on Pharmac Special Authority criteria: Temporary removal of specified dose regimen for nivolumab and pembrolizumab during COVID crisis  
  • Collaborative use of new genomic technologies to monitor melanoma 
 
8 November 2019
Auckland
_______


Topics discussed: 

  • Pharmac changes to funding criteria for pembrolizumab and nivolumab for advanced melanoma 
  • National immunotherapy database
 
14 June 2019
Auckland
_______


Topics discussed: 

  • Increasing clinical trials in New Zealand and improving access
  • Auditing and standardisation of immune checkpoint inhibitor data
 
15 March 2018
Auckland
_______


Topics discussed: 

  • Results of sentinel node data international trials and their application in New Zealand 
  • Melanoma tissue banking practices in New Zealand 
Please contact us for highlights and outcomes of past meetings.